1. Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?

   • Wendy H. Updike
   • Olivia Pane
   • Nicholas W. Carris

   Current Opinion 30 April 2021 Pages: 881 - 893

2. IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses

   • Youkyung S. Roh
   • Justin Choi
   • Shawn G. Kwatra

   Leading Article 21 April 2021 Pages: 895 - 905

   

3. Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review

   • Marta S. Palmeirim
   • Sabine Specht
   • Jennifer Keiser

   Review Article Open access 30 April 2021 Pages: 907 - 921

   

4. Targeting AMPK by Statins: A Potential Therapeutic Approach

   • Sajad Dehnavi
   • Amirhossein Kiani
   • Amirhossein Sahebkar

   Review Article Open access 03 May 2021 Pages: 923 - 933

   

5. Fostamatinib: A Review in Chronic Immune Thrombocytopenia

   • Julia Paik

   Adis Drug Evaluation 10 May 2021 Pages: 935 - 943

   

6. Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia

   • Connie Kang
   • Yahiya Y. Syed

   Adis Drug Evaluation 10 May 2021 Pages: 945 - 952

7. Fosdenopterin: First Approval

   • Connie Kang

   AdisInsight Report 28 April 2021 Pages: 953 - 956

   

8. Ponesimod: First Approval

   • Anthony Markham

   AdisInsight Report 03 May 2021 Pages: 957 - 962

   

9. Melphalan Flufenamide (Melflufen): First Approval

   • Sohita Dhillon

   AdisInsight Report 07 May 2021 Pages: 963 - 969